Anil Singhal has become chief drug development officer of Martinsried, Germany-based Xerion Pharmaceuticals. He will be based in the company’s Cambridge, Mass., office. Previously, he was vice president at Light Sciences and Pacific Pharmaceuticals, where he led oncology programs through preclinical and clinical stages of development.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.